Mechanisms of the Age-Associated Deterioration in Glucose Tolerance

Abstract

Glucose tolerance decreases with age. For determining the cause of this decrease, 67 elderly and 21 young (70.1 ؎ 0.7 vs. 23.7 ؎ 0.8 years) participants ingested a mixed meal and received an intravenous injection of glucose. Fasting glucose and the glycemic response above basal were higher in the elderly than in the young participants after either meal ingestion (P < 0.001) or glucose injection (P < 0.01). Insulin action (Si), measured with the meal and intravenous glucose tolerance test models, was highly correlated (r ‫؍‬ 0.72; P < 0.001) and lower (P < 0.002) in the elderly than in the young participants. However, when adjusted for differences in percentage body fat and visceral fat, Si no longer differed between groups. When considered in light of the degree of insulin resistance, all indexes of insulin secretion were lower (P < 0.01) in the elderly participants, indicating impaired ␤-cell function. Hepatic insulin clearance was increased (P < 0.002), whereas total insulin clearance was decreased (P < 0.002) in the elderly subjects. Multivariate analysis (r ‫؍‬ 0.70; P < 0.001) indicated that indexes of insulin action (Si) and secretion (Phi total ) but not age, peak oxygen uptake, fasting glucose, degree of fatness, or hepatic insulin clearance predicted the postprandial glycemic response. We conclude that the deterioration in glucose tolerance that occurs in healthy elderly subjects is due to a decrease in both insulin secretion and action with the severity of the defect in insulin action being explained by the degree of fatness rather than age per se. Diabetes

Postnatal exposure to voluntary exercise but not the antioxidant catechin protects the vasculature after a switch to an atherogenic environment in middle-age mice

“…Glycemia was high at 9 months of age in all groups (Table 1) compared to 3-month-old mice [5]; this age-dependent increase in circulating glucose has been reported in rat [55], monkey [41], and human [3].…”

Postprandial hyperglycemia and hyperinsulinemia associated with renal arterio-arteriolosclerosis in chronic kidney disease

“…Stepwise multiple regression analysis showed that hypertension, S-Cr and 2-h PG were independently associated with renal arterio-arteriolosclerosis (Table 4). Generally, aging is related to renal pathological changes 22 and glucose intolerance/insulin resistance, 23 but all indices but BMI were not in this study, as shown in Table 5.…”

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

“…In the present study, such an improvement of beta cell function may make a lesser contribution to the efficacy of vildagliptin, due to chronic exposure of patients to high insulin levels of exogenous origin. Since elderly subjects have been reported to have significantly higher plasma glucagon levels than younger people [15], vildagliptin-mediated suppression of inappropriate glucagon secretion may contribute to the greater efficacy observed in elderly as compared with younger patients. In addition, older patients with type 2 diabetes tend to have a predominant postprandial hyperglycaemia [16], which is addressed by the robust effect of vildagliptin on postprandial hyperglycaemia [5].…”